Inovio Pharmaceuticals
INO
#8713
Rank
HK$0.82 B
Marketcap
HK$31.59
Share price
2.27%
Change (1 day)
-19.59%
Change (1 year)

P/E ratio for Inovio Pharmaceuticals (INO)

P/E ratio as of November 2024 (TTM): -6.25

According to Inovio Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.24615. At the end of 2022 the company had a P/E ratio of -15.9.

P/E ratio history for Inovio Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-15.9-61.58%
2021-41.3-58%
2020-98.3200.46%
2019-32.7-28.41%
2018-45.7-2.23%
2017-46.8-43.3%
2016-82.5-55.01%
2015-1833.15%
2014-17878.7%
2013-99.4140.29%
2012-41.4-3.77%
2011-43.0-50.14%
2010-86.3133.28%
2009-37.077.75%
2008-20.8-49.13%
2007-40.9-52.36%
2006-85.8341.1%
2005-19.5-73.25%
2004-72.7108.52%
2003-34.961.5%
2002-21.6-57.81%
2001-51.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
13.5-316.31%๐Ÿ‡บ๐Ÿ‡ธ USA
11.0-276.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-10.8 72.15%๐Ÿ‡บ๐Ÿ‡ธ USA
27.8-544.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
54.8-977.62%๐Ÿ‡บ๐Ÿ‡ธ USA
9.63-254.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
20.4-427.35%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.